Skip to main content
HR 3368 110th Congress House Health Clinical trials Congress Congressional investigations Congressional reporting requirements Economics and Public Finance Education Federal aid to research Government Operations and Politics Government publicity Health education Higher education Hypertension Lung diseases Medicaid Medical education Medical research Medicare Research grants Science, Technology, Communications

Pulmonary Hypertension Research and Education Act of 2007

Introduced: August 3, 2007 See on congress.gov
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 13, 2007
Referred to the Subcommittee on Health.
Aug 3, 2007
Referred to the Subcommittee on Health.
Aug 3, 2007
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Aug 3, 2007
Sponsor introductory remarks on measure. (CR 8/4/2007 E1755)
Aug 3, 2007
Introduced in House
 Plain-English summary Congressional Research Service

Pulmonary Hypertension Research and Education Act of 2007 - Amends the Public Health Service Act to require the Director of the National Heart, Lung, and Blood Institute to expand, intensify, and coordinate the Institute's pulmonary hypertension research activities.

Requires the Director to establish a Pulmonary Hypertension Clinical Research Network to conduct clinical trials to evaluate new treatment approaches for pulmonary hypertension and facilitate collaboration among investigators with expertise in pulmonary hypertension. Directs the network to include: (1) a steering committee; and (2) an Institute project scientist.

Provides for the establishment of a national Pulmonary Hypertension Preceptorship and Training Program to facilitate the direct education and training of medical professionals by experienced pulmonary hypertension specialists in clinical settings.

Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to develop and disseminate to the public information regarding pulmonary hypertension.

Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA) and the Director of CDC, to develop and disseminate to health care providers information on pulmonary hypertension to ensure that providers remain informed about the disease, its presenting symptoms, and current treatment options.

Requires the Comptroller General to conduct a study on the coverage standards that apply to individuals with pulmonary hypertension under Medicare and Medicaid.

What's happening now August 13, 2007

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4